Literature DB >> 25701230

The utility of IgM, CD21, HGAL and LMO2 in the diagnosis of pediatric follicular lymphoma.

Tejashree Karnik1, Michael G Ozawa2, Martina Lefterova2, Sandra Luna-Fineman3, Elysia Alvarez3, Michael Link3, James L Zehnder2, Daniel A Arber2, Robert S Ohgami4.   

Abstract

Pediatric follicular lymphoma (pFL) is a rare neoplasm with features differing from follicular lymphoma arising in adults. Here, we describe a rare case of pFL that showed morphologic features partially overlapping with progressive transformation of germinal centers and reactive follicular hyperplasia. As typical of pFL, neoplastic B cells within follicles did not express B-cell leukemia/lymphoma 2 (BCL2). However, this case showed additional distinctive abnormal findings, which contributed to the diagnosis: (1) diffuse and uniform staining of immunoglobulin M (IgM) on cells within and outside of follicles, (2) abnormally dim expression of CD21 on follicular dendritic cells, and (3) expression of human germinal center-associated lymphoma (HGAL) and LIM domain only 2 (LMO2) on B cells in interfollicular and follicular areas. This case demonstrates the utility of these abnormal features, which can be seen in adult- or usual-type follicular lymphoma, in the diagnosis of pFL. Further studies are necessary to evaluate the significance of these findings in other cases of pFL.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult follicular lymphoma; HGAL; IgM; LMO2; Pediatric follicular lymphoma

Mesh:

Substances:

Year:  2015        PMID: 25701230     DOI: 10.1016/j.humpath.2014.12.016

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  1 in total

1.  A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.

Authors:  Michael G Ozawa; Aparna Bhaduri; Karen M Chisholm; Steven A Baker; Lisa Ma; James L Zehnder; Sandra Luna-Fineman; Michael P Link; Jason D Merker; Daniel A Arber; Robert S Ohgami
Journal:  Mod Pathol       Date:  2016-06-24       Impact factor: 7.842

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.